IQVIA HOLDINGS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
IQVIA HOLDINGS INC. (IQV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 875 shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2021-02-12
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2020 was 875.00 shares, a 94.68% decline from fiscal 2019.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2019 was 16.45K shares, a 62.25% decline from fiscal 2018.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2018 was 43.59K shares, a 79.52% decline from fiscal 2017.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2017 was 212.89K shares, a 40.48% decline from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|
| 2020-12-31 | 875.00 shares 10-K · filed 2021-02-12 |
| 2019-12-31 | 16.45K shares 10-K · filed 2020-02-18 |
| 2018-12-31 | 43.59K shares 10-K · filed 2019-02-19 |
| 2017-12-31 | 212.89K shares 10-K · filed 2018-02-16 |
| 2016-12-31 | 357.68K shares 10-K · filed 2017-02-16 |
| 2015-12-31 | 457.37K shares 10-K · filed 2016-02-11 |
| 2014-12-31 | 574.63K shares 10-K · filed 2015-02-12 |
| 2013-12-31 | 410.87K shares 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |